Grace Therapeutics
GRCE
16 hedge funds and large institutions have $6.71M invested in Grace Therapeutics in 2014 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 0 closing their positions.
45% more capital invested
Capital invested by funds: $4.63M → $6.71M (+$2.08M)
33% more funds holding
Funds holding: 12 → 16 (+4)
83% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
+$1.61M |
| 2 |
IIM
Intact Investment Management
Montreal,
Quebec, Canada
|
+$1.37M |
| 3 |
Jane Street
New York
|
+$29.6K |
| 4 |
U
UBS
Zurich,
Switzerland
|
+$12.4K |
| 5 |
TAM
Tocqueville Asset Management
New York
|
+$477 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$301K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$72.6K |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$20.1K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$16.2K |
| 5 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
-$4.3K |
GRCE Hedge Fund Activity: Q2 2014 in Review
16 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in Grace Therapeutics (GRCE) for Q2 2014, worth a combined $6.71M — up 45% from $4.63M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new GRCE positions and 0 closed out — a net gain of 4 holders — while 1 added to existing stakes and 6 trimmed.
The largest buyer was Fiera Capital (Canada), opening a new position worth an estimated $1.61M. The largest seller was Perceptive Advisors, cutting an estimated $301K.
- 16 institutional investors held Grace Therapeutics (GRCE) as of Q2 2014, up from 12 in Q1 2014.
- Funds reported $6.71M of Grace Therapeutics stock for Q2 2014, up 45% quarter-over-quarter.
- 4 funds opened new Grace Therapeutics positions in Q2 2014 and 0 closed out, a net change of +4 holders.
- The largest Grace Therapeutics buyer in Q2 2014 was Fiera Capital (Canada), an estimated $1.61M added.
- The largest Grace Therapeutics seller in Q2 2014 was Perceptive Advisors, an estimated $301K sold.
Based on aggregated 13F filings for Q2 2014.